2-Chloro-1,5-dimethyl-1H-imidazole | 1891417-40-5

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑类
• 英文名称: 2-Chloro-1,5-dimethyl-1H-imidazole
• 英文别名: 2-chloro-1,5-dimethylimidazole
• CAS: 1891417-40-5
• 化学式: C₅H₇ClN₂
• 分子量: 130.57
• InChiKey: ZZYICRCDLICFHF-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.4
• 重原子数：
  8
• 可旋转键数：
  0
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.4
• 拓扑面积：
  17.8
• 氢给体数：
  0
• 氢受体数：
  1

文献信息

• 2-(HET)ARYL-SUBSTITUTED FUSED BICYCLIC HETEROCYCLE DERIVATIVES AS PESTICIDES
  申请人：BAYER CROPSCIENCE AKTIENGESELLSCHSAFT

  公开号：US20180002345A1

  公开（公告）日：2018-01-04

  The invention relates to novel compounds of the formula (I) in which the R 1 , R 2a , R 2b , R 3 , A 1 , A 2 , A 3 , A 4 and n radicals are each as defined above, to their use as acaricides and/or insecticides for controlling animal pests and to processes and intermediates for their preparation.

  本发明涉及公式（I）的新化合物，其中R1、R2a、R2b、R3、A1、A2、A3、A4和n基团的定义如上所述，它们的用途是作为杀螨剂和/或杀虫剂用于控制动物害虫，以及用于它们的制备的过程和中间体。
• SPIRO-OXINDOLE COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS
  申请人：Chafeev Mikhail

  公开号：US20100137299A1

  公开（公告）日：2010-06-03

  This invention is directed to spiro-oxindole compounds, as stereoisomers, enantiomers, tautomers thereof or mixtures thereof; or pharmaceutically acceptable salts, solvates or prodrugs thereof, for the treatment and/or prevention of sodium channel-mediated diseases or conditions, such as pain.

  本发明涉及螺环氧吲哚化合物，包括其立体异构体、对映异构体、互变异构体或其混合物；或其药学上可接受的盐、溶剂化合物或前药，用于治疗和/或预防钠通道介导的疾病或症状，例如疼痛。
• SPIRO-OXINDOLE COMPOUNDS AND THEIR USES AS THERAPEUTIC AGENTS
  申请人：Chafeev Mikhail

  公开号：US20120295897A1

  公开（公告）日：2012-11-22

  This invention is directed to spiro-oxindole compounds, as stereoisomers, enantiomers, tautomers thereof or mixtures thereof; or pharmaceutically acceptable salts, solvates or prodrugs thereof, for the treatment and/or prevention of sodium channel-mediated diseases or conditions, such as pain.

  本发明涉及螺环氧吲哚化合物，包括立体异构体、对映体、互变异构体或其混合物；或其药学上可接受的盐、溶剂合物或前药，用于治疗和/或预防钠通道介导的疾病或病症，例如疼痛。
• 2-(HET)ARYL-SUBSTITUIERTE KONDENSIERTE BICYCLISCHE HETEROCYCLEN-DERIVATE ALS SCHÄDLINGS-BEKÄMPFUNGSMITTEL
  申请人：Bayer CropScience Aktiengesellschaft

  公开号：EP3253210B1

  公开（公告）日：2021-11-24
• US8263606B2
  申请人：——

  公开号：US8263606B2

  公开（公告）日：2012-09-11